Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Altered {beta}-catenin accumulation in hepatocellular carcinomas of diethylnitrosamine-exposed rhesus macaques.

Wei BR, Edwards JB, Hoover SB, Tillman HS, Reed LT, Sills RC, Simpson RM.

Toxicol Pathol. 2008 Dec;36(7):972-80. doi: 10.1177/0192623308327120. Epub 2008 Oct 31.

2.

Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma.

Austinat M, Dunsch R, Wittekind C, Tannapfel A, Gebhardt R, Gaunitz F.

Mol Cancer. 2008 Feb 18;7:21. doi: 10.1186/1476-4598-7-21.

3.

β-Catenin signaling in hepatocellular cancer: Implications in inflammation, fibrosis, and proliferation.

Lee JM, Yang J, Newell P, Singh S, Parwani A, Friedman SL, Nejak-Bowen KN, Monga SP.

Cancer Lett. 2014 Feb 1;343(1):90-7. doi: 10.1016/j.canlet.2013.09.020. Epub 2013 Sep 23.

4.

Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations.

Audard V, Grimber G, Elie C, Radenen B, Audebourg A, Letourneur F, Soubrane O, Vacher-Lavenu MC, Perret C, Cavard C, Terris B.

J Pathol. 2007 Jul;212(3):345-52.

PMID:
17487939
5.

β-catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features: immunohistochemical and mutational study.

Ando S, Shibahara J, Hayashi A, Fukayama M.

Virchows Arch. 2015 Nov;467(5):535-42. doi: 10.1007/s00428-015-1836-2. Epub 2015 Aug 27.

PMID:
26311355
6.

β-Catenin loss in hepatocytes promotes hepatocellular cancer after diethylnitrosamine and phenobarbital administration to mice.

Awuah PK, Rhieu BH, Singh S, Misse A, Monga SP.

PLoS One. 2012;7(6):e39771. doi: 10.1371/journal.pone.0039771. Epub 2012 Jun 25.

7.

L-Asparaginase and inhibitors of glutamine synthetase disclose glutamine addiction of β-catenin-mutated human hepatocellular carcinoma cells.

Tardito S, Chiu M, Uggeri J, Zerbini A, Da Ros F, Dall'Asta V, Missale G, Bussolati O.

Curr Cancer Drug Targets. 2011 Oct;11(8):929-43.

PMID:
21834755
8.

Suppression of beta-catenin mutation by dietary exposure of auraptene, a citrus antioxidant, in N,N-diethylnitrosamine-induced hepatocellular carcinomas in rats.

Hara A, Sakata K, Yamada Y, Kuno T, Kitaori N, Oyama T, Hirose Y, Murakami A, Tanaka T, Mori H.

Oncol Rep. 2005 Aug;14(2):345-51.

PMID:
16012713
9.

Wnt/beta-catenin signaling pathway in hepatocellular carcinomas cases from Colombia.

Suarez M I, Uribe D, Jaramillo CM, Osorio G, Perez JC, Lopez R, Hoyos S, Hainaut P, Pineau P, Navas MC.

Ann Hepatol. 2015 Jan-Feb;14(1):64-74.

10.

Krüppel-like factor 8 is a new Wnt/beta-catenin signaling target gene and regulator in hepatocellular carcinoma.

Yang T, Cai SY, Zhang J, Lu JH, Lin C, Zhai J, Wu MC, Shen F.

PLoS One. 2012;7(6):e39668. doi: 10.1371/journal.pone.0039668. Epub 2012 Jun 27.

11.

Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis.

Devereux TR, Anna CH, Foley JF, White CM, Sills RC, Barrett JC.

Oncogene. 1999 Aug 19;18(33):4726-33.

12.

Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas.

Zucman-Rossi J, Benhamouche S, Godard C, Boyault S, Grimber G, Balabaud C, Cunha AS, Bioulac-Sage P, Perret C.

Oncogene. 2007 Feb 1;26(5):774-80. Epub 2006 Sep 11.

PMID:
16964294
13.

Complete response of Ctnnb1-mutated tumours to β-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis model.

Delgado E, Okabe H, Preziosi M, Russell JO, Alvarado TF, Oertel M, Nejak-Bowen KN, Zhang Y, Monga SP.

J Hepatol. 2015 Feb;62(2):380-7. doi: 10.1016/j.jhep.2014.10.021. Epub 2014 Oct 18.

14.

Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin.

Nejak-Bowen KN, Thompson MD, Singh S, Bowen WC Jr, Dar MJ, Khillan J, Dai C, Monga SP.

Hepatology. 2010 May;51(5):1603-13. doi: 10.1002/hep.23538.

15.

Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas.

Yu B, Yang X, Xu Y, Yao G, Shu H, Lin B, Hood L, Wang H, Yang S, Gu J, Fan J, Qin W.

J Hepatol. 2009 May;50(5):948-57. doi: 10.1016/j.jhep.2008.11.020. Epub 2009 Jan 9.

PMID:
19303159
16.

Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.

Ding SL, Yang ZW, Wang J, Zhang XL, Chen XM, Lu FM.

World J Gastroenterol. 2015 May 28;21(20):6317-28. doi: 10.3748/wjg.v21.i20.6317. Review.

17.

Alterations of Wnt/β-catenin signaling pathway in hepatocellular carcinomas associated with hepatitis C virus.

Rogacki K, Kasprzak A, Stępiński A.

Pol J Pathol. 2015 Mar;66(1):9-21. Review.

18.

Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis.

Liu L, Zhu XD, Wang WQ, Shen Y, Qin Y, Ren ZG, Sun HC, Tang ZY.

Clin Cancer Res. 2010 May 15;16(10):2740-50. doi: 10.1158/1078-0432.CCR-09-2610. Epub 2010 May 11.

19.

CTNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1.

Devereux TR, Stern MC, Flake GP, Yu MC, Zhang ZQ, London SJ, Taylor JA.

Mol Carcinog. 2001 Jun;31(2):68-73.

PMID:
11429783
20.

[Expression of β-catenin and HNF-1α and their influence on prognosis in human hepatocellular carcinoma].

Shi J, Yin F.

Zhonghua Zhong Liu Za Zhi. 2014 Aug;36(8):587-91. Chinese.

PMID:
25430024

Supplemental Content

Support Center